Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses

Management of hypersensivity pneumonitis

(2013) Ioana O Agache et al.   Clinical and Translational Allergy

Prevention and handling of acute allergic and infusion reactions in oncology

(2012) M. Joerger   ANNALS OF ONCOLOGY

Rituximab-induced interstitial lung disease in a patient with immune thrombocytopenia purpura

(2012) N. Child et al.   INTERNAL MEDICINE JOURNAL

Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab

(2012) Alessandra Vultaggio et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Denosumab: mechanism of action and clinical outcomes

(2012) D. A. Hanley et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia

(2012) D. M. ARNOLD et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

(2012) Peter D Senter et al.   NATURE BIOTECHNOLOGY

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches

(2012) Osamu Matsuno   RESPIRATORY RESEARCH

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis

(2011) J. Cortes et al.   ANNALS OF ONCOLOGY

Trastuzumab Has Preferential Activity against Breast Cancers Driven by HER2 Homodimers

(2011) R. Ghosh et al.   CANCER RESEARCH

One target, different effects: a comparison of distinct therapeutic antibodies against the same targets

(2011) Hyunbo Shim   EXPERIMENTAL AND MOLECULAR MEDICINE

Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura

(2011) G. Le Guenno et al.   INTERNAL MEDICINE JOURNAL

Rituximab Associated Pneumonitis in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2011) Nishkantha Arulkumaran et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

The Tumor Lysis Syndrome

(2011) Scott C. Howard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-infectious pulmonary toxicity of rituximab: a systematic review

(2011) A. V. Hadjinicolaou et al.   RHEUMATOLOGY

Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options?

(2011) Gary R Epler   Expert Review of Respiratory Medicine

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods

(2010) J. A. Reese et al.   BLOOD

Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia

(2010) William G. Wierda et al.   CANCER

U.S. Food and Drug Administration Approval: Ofatumumab for the Treatment of Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine and Alemtuzumab

(2010) S. J. Lemery et al.   CLINICAL CANCER RESEARCH

Ofatumumab

(2010) Bodi Zhang   mAbs

Catumaxomab

(2010) Rolf Linke et al.   mAbs

Late-Onset Neutropenia After Rituximab Treatment

(2010) Ofir Wolach et al.   MEDICINE

The safety and side effects of monoclonal antibodies

(2010) Trevor T. Hansel et al.   NATURE REVIEWS DRUG DISCOVERY

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

(2010) Anas Younes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab-Associated Neutropenia

(2010) Kieron Dunleavy et al.   SEMINARS IN HEMATOLOGY

Mechanisms of Immune-Mediated Liver Injury

(2010) David H. Adams et al.   TOXICOLOGICAL SCIENCES

CTLA-4 blockade: therapeutic potential in cancer treatments

(2010) Ahmad Tarhini   OncoTargets and Therapy

Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study

(2009) K. Brockow et al.   ALLERGY

Understanding and managing the possible adverse effects associated with bevacizumab

(2009) S. S. Shord et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Rituximab-associated acute thrombocytopenia: An under-diagnosed phenomenon

(2009) Ron Ram et al.   AMERICAN JOURNAL OF HEMATOLOGY

Drug-induced thrombocytopenia induced by trastuzumab: a special challenge in a curable disease

(2009) C. Jara Sanchez et al.   ANNALS OF ONCOLOGY

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Anaphylaxis After Administration of Ibritumomab Tiuxetan for Follicular Non-Hodgkin Lymphoma

(2009) Rachel Jankowitz et al.   CLINICAL NUCLEAR MEDICINE

MANAGEMENT OF SKIN RASH DURING EGFR-TARGETED MONOCLONAL ANTIBODY TREATMENT FOR GASTRO INTESTINAL MALIGNANCIES: CANADIAN RECOMMENDATIONS

(2009) Barb Melosky et al.   Current Oncology

Rituximab-induced lung disease: a systematic literature review

(2009) H. Liote et al.   EUROPEAN RESPIRATORY JOURNAL

Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model

(2009) Yanping Hu et al.   IMMUNOLOGY

Rituximab-induced vasculitis: A case report and review of the medical published work

(2009) Min Joo KIM et al.   JOURNAL OF DERMATOLOGY

Association of cetuximab with adverse pulmonary events in cancer patients: a comprehensive review

(2009) Jeffrey B Hoag et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Severe respiratory adverse events associated with rituximab infusion

(2009) Koichi Kamei et al.   PEDIATRIC NEPHROLOGY

Fatal pulmonary fibrosis after rituximab administration

(2009) Marie-Camille Chaumais et al.   PEDIATRIC NEPHROLOGY

A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus

(2009) J. Kishi et al.   RHEUMATOLOGY

Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab

(2008) Joshua Ruch et al.   AMERICAN JOURNAL OF HEMATOLOGY

Severe Thrombocytopenia Induced by a Single Infusion of Trastuzumab

(2008) Omi Parikh et al.   Clinical Breast Cancer

Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients

(2008) Shobha Rani Nalluri et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment

(2008) Lawrence Fong et al.   JOURNAL OF CLINICAL ONCOLOGY

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

(2008) Christine H. Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing Premedications and the Risk for Reactions to Infusional Monoclonal Antibody Therapy

(2008) C. H. Chung   ONCOLOGIST

Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab

(2007) Shinichi Kako et al.   AMERICAN JOURNAL OF HEMATOLOGY